Antifungal activity of dexamethasone against fluconazole-resistant Candida albicans and its activity against biofilms
- PMID: 35411812
- DOI: 10.2217/fmb-2021-0146
Antifungal activity of dexamethasone against fluconazole-resistant Candida albicans and its activity against biofilms
Erratum in
-
Corrigendum.Future Microbiol. 2022 Aug;17:983. doi: 10.2217/fmb-2021-0146c1. Epub 2022 Jun 13. Future Microbiol. 2022. PMID: 35695896 No abstract available.
Abstract
Objective: The present study investigated the antifungal action of dexamethasone disodium phosphate (Dex). Methodology: Susceptibility testing was performed using the Clinical & Laboratory Standards Institute protocol; M27-A3, checkerboard test and biofilm were evaluated with two isolates of Candida albicans, hyphal production test, molecular docking analysis and flow cytometry analysis. Result: Dex and fluconazole (FLC) together had a synergistic effect. Mature biofilm was reduced when treated with Dex alone or in combination. Dex and FLC promoted a decrease in the production of hyphae and changes in the level of mitochondrial depolarization, increased generation of reactive oxygen species, loss of membrane integrity, increased phosphatidylserine externalization and molecular docking; there was interaction with ALS3 and SAP5 targets. Conclusion: Dex showed antifungal activity against FLC-resistant C. albicans strains.
Keywords: Candida spp.; biofilm; dexamethasone; repositioning.
Plain language summary
This study aimed to evaluate the antifungal action of dexamethasone against FLC-resistant C. albicans strains.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous